HomeBCT • TSE
add
Briacell Therapeutics Corp
Previous close
$13.44
Year range
$8.40 - $141.00
Market cap
25.32M CAD
Avg Volume
4.24K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Oct 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.32M | 61.52% |
Net income | -8.20M | -41.28% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -8.30M | -61.84% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Oct 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.18M | 75.68% |
Total assets | 13.08M | 25.55% |
Total liabilities | 3.72M | -44.42% |
Total equity | 9.35M | — |
Shares outstanding | 1.88M | — |
Price to book | 2.54 | — |
Return on assets | -119.84% | — |
Return on capital | -155.95% | — |
Cash Flow
Net change in cash
| (USD) | Oct 2025info | Y/Y change |
|---|---|---|
Net income | -8.20M | -41.28% |
Cash from operations | -7.70M | -10.78% |
Cash from investing | -75.00K | 0.00% |
Cash from financing | — | — |
Net change in cash | -7.78M | -257.80% |
Free cash flow | -4.65M | 7.58% |
About
Founded
2006
Headquarters
Website
Employees
22
